Active Ingredient History
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people, routine immunization results in more than 95% of people being protected. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Hepatitis B Vaccines (approved 1986)
Acute-On-Chronic Liver Failure (Phase 4)
Aging (Phase 4)
Anesthesia (Phase 4)
Apnea (Phase 4)
Bacterial Infections (Phase 3)
Breast Neoplasms (Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Chickenpox (Phase 4)
Colorectal Neoplasms (Phase 1)
Communicable Diseases (Phase 2/Phase 3)
Cross Infection (Phase 4)
Digestive System Diseases (Phase 4)
Diphtheria (Phase 4)
Diphtheria-Tetanus-Pertussis Vaccine (Phase 3)
Diphtheria Toxoid (Phase 2)
DNA Virus Infections (Phase 3)
Esophageal and Gastric Varices (Phase 2)
Fibrosis (Phase 3)
Haemophilus influenzae (Phase 3)
Haemophilus influenzae type b (Phase 4)
Hand, Foot and Mouth Disease (Phase 4)
Healthy Volunteers (Phase 4)
Hepadnaviridae Infections (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis B Vaccines (Phase 4)
Hepatitis B virus (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis, Viral, Human (Phase 4)
HIV (Phase 4)
HIV Infections (Phase 4)
Hookworm Infections (Phase 1)
Hospitalization (Phase 4)
Immunity (Phase 4)
Immunization (Phase 4)
Infant, Premature, Diseases (Phase 4)
Inflammatory Bowel Diseases (Phase 2/Phase 3)
Kidney Failure, Chronic (Phase 4)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 4)
Liver Neoplasms (Phase 4)
Liver Transplantation (Phase 1/Phase 2)
Lymphoproliferative Disorders (Phase 4)
Malaria (Phase 3)
Malaria Vaccines (Phase 3)
Measles (Phase 2)
Meninges (Phase 2)
Meningitis (Phase 2)
Meningitis, Meningococcal (Phase 3)
Meningococcal Infections (Phase 3)
Mortality (Phase 4)
Mumps Vaccine (Phase 2)
Neisseria meningitidis (Phase 3)
Organ Transplantation (Phase 3)
Pancreatic Neoplasms (Phase 1)
Papillomavirus Infections (Phase 4)
Papillomavirus Vaccines (Phase 3)
Peritoneal Dialysis (Phase 4)
Pertussis Vaccine (Phase 4)
Pneumococcal Infections (Phase 3)
Pneumococcal Vaccines (Phase 3)
Pneumonia, Pneumococcal (Phase 1/Phase 2)
Poliomyelitis (Phase 4)
Poliovirus Vaccines (Phase 2)
Renal Insufficiency (Phase 2/Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Rubella Vaccine (Phase 2)
Safety (Phase 3)
Schistosoma mansoni (Phase 1/Phase 2)
Schistosomiasis (Phase 1/Phase 2)
Seroepidemiologic Studies (Phase 4)
Streptococcal Infections (Phase 3)
Streptococcus pneumoniae (Phase 3)
Tetanus (Phase 4)
Urinary Bladder Neoplasms (Phase 1)
Vaccination (Phase 4)
Vaccines (Phase 4)
Virus Diseases (Phase 3)
Whooping Cough (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
